The living donor kidney transplant should be considered a priority option providing better quality of life and survival for those needing renal replacement therapy. To increase their number, both nephrologists and patients, should be informed more and better, offering this option compared with LDKT alternatives (dialysis or kidney transplant from a deceased donor). The clinical nephrology consultations or specific pre-dialysis are the space where in stages 3 and 4 of renal failure should be started on LDKT informational approaches. Later, when seeking more detailed information and/or evaluation of potential donors, this could be provided at times and spaces specifically reserved for awareness professionals with the use of brochures or Internet addresses. Information should focus especially on the additional benefits of pre-emptive LDKT, the risks of nephrectomy and long term controls for the donor. Finally, donor, recipient and family should know that the donation will only be justified and may be accepted if the studies of risk/benefit for the donor and recipient have been faithfully evaluated according to the highest ethical standards.